Butterfly Network (BFLY) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary

Strategic and financial highlights

• Achieved 25% annual revenue growth in 2024, with quarterly growth accelerating from 14% to 35% by Q4.

• Underwent significant restructuring in 2023, focusing on cost reduction and business alignment.

• Revenue mix is 70% hardware and 30% software, with software share expected to rise.

• Secured major awards, including the Prix Galien and Fierce 50, for innovation and societal impact.

• Launched a pilot with Optum to provide imaging services in skilled nursing facilities.

Technology and product innovation

• Commercialized the first MEMS semiconductor for ultrasound, enabling a single device to replace multiple probes.

• Launched the third-generation iQ3 device in February, doubling processing power and improving image quality.

• Fourth-generation chip achieves image quality rivaling top hospital carts at a fraction of the cost.

• Fifth-generation chip, expected in 3–5 years, will have 20x current processing power.

• Devices are fully networked, receiving regular software updates and new AI features.

Market development and adoption

• Handheld ultrasound market is expanding, with growing adoption in hospitals, clinics, and home care.

• 70% of medical schools now train students on Butterfly devices; 20 campus stores offer discounted units.

• Viral adoption among individual doctors, with 1,000 devices sold per quarter directly to clinicians.

• Enterprise software increases image capture rates, boosting hospital revenue and efficiency.

• AI-powered ScanLab and educational tools accelerate competency and usage among students.